To examine the molecular epidemiology of influenza virus transmission, the nucleotide sequences of the HA1 domain of the hemagglutinin (HA) gene of 57 influenza A and 24 influenza B viruses recovered in a single season were analyzed. No nucleotide sequence differences were found among the 10 viruses that were recovered twice from the same patient. The nucleotide sequences of influenza A viruses were identical within each family but varied among the 14 families included in the study. The sequences of influenza A viruses recovered from 18 residents of the same community showed that 83% of the viruses differed from the others by at least 1 nucleotide residue. These findings indicate that most cases of influenza in households in which 1 family member has been infected are the result of secondary transmission from the index patient and not of acquisition from other community sources. Substantial genetic conservation during virus transmission within households is indicated.
To examine the molecular epidemiology of influenza virus transmission, the nucleotide sequences of the HA1 domain of the hemagglutinin (HA) gene of 57 influenza A and 24 influenza B viruses recovered in a single season were analyzed. No nucleotide sequence differences were found among the 10 viruses that were recovered twice from the same patient. The nucleotide sequences of influenza A viruses were identical within each family but varied among the 14 families included in the study. The sequences of influenza A viruses recovered from 18 residents of the same community showed that 83% of the viruses differed from the others by at least 1 nucleotide residue. These findings indicate that most cases of influenza in households in which 1 family member has been infected are the result of secondary transmission from the index patient and not of acquisition from other community sources. Substantial genetic conservation during virus transmission within households is indicated.
Influenza A and B viruses have a worldwide distribution and cause annual outbreaks of variable intensity. They exist as quasi species because of an error-prone replication of the viral genome by RNA polymerase [1] . Although there are fundamental differences in the evolution and epidemiology of influenza A and B viruses [2] , both types undergo antigenic drift [3] . The antigenic drift of hemagglutinin (HA), a major surface antigen, plays an important role in influenza virus escape from host immune defense and necessitates annual reevaluation of vaccine composition. The amino acid substitutions that result in antigenic drift accumulate primarily in 5 antigenic regions, located on the HA1 subunit of the HA molecule [3] .
Genetic variation has an important influence on the antigenic diversification of RNA viruses [1] . In addition to reassortment of viral genes (antigenic shift) [3] , the recognized contributors to genetic variation in human influenza viruses include selection of escape variants by antibodies [4, 5] and by antivirals [6, 7] and selection of receptor-binding variants [8] [9] [10] . For example, serum samples from young children have shown the capacity to select antigenic variants of influenza A viruses [5] . Virus variants could also emerge as a result of random sampling events, such as transmission of a small fraction of heterogeneous populations of virus genomes replicating in a single patient [1] or as the result of obscure mechanisms that cause oscillation of quasi species during prolonged influenza virus shedding in immmunocompromised patients [11] .
Households are important sites for transmission of influenza viruses, and children play an essential role in virus dissemination [12] [13] [14] . Nonetheless, the sequence heterogeneity of the HA gene of viruses transmitted within families has not been ascertained. Sequence analysis is a useful molecular tool for the epidemiologic investigation of influenza outbreaks that allows refinement of our ability to differentiate between virus isolates.
Recently, we reported the results of a study that assessed the efficacy of the inhaled neuraminidase inhibitor zanamivir in preventing transmission of influenza virus infections in families [15] . In the present study, we applied the HA gene sequence data accumulated in this trial to investigate the molecular epidemiology of virus transmission in the households. The analysis was complemented by the assessment of the sequence heterogeneity of virus isolates from the residents of the same community.
Subjects, Materials, and Methods

Patients and families.
To evaluate the prophylactic efficacy of the neuraminidase inhibitor zanamivir, 337 families were enrolled in a study conducted in the United States, Canada, and the United Kingdom during the influenza season of 1998-1999 [15] . Families in which all members resided in the same household and which consisted of 2-5 members (including at least 1 adult у18 years old and 1 child between the ages of 5 and 17 years) were eligible. Family members who met any of the following criteria were not assigned to receive zanamivir or placebo: age !5 years, hypersensitivity to zanamivir, immunocompromised state, use of an anti-influenza agent other than zanamivir, pregnancy, or breast-feeding. When influenza was documented in a particular community, all eligible members of families experiencing the introduction of an influenzalike illness were randomly assigned, by household, to receive inhaled zanamivir or placebo. Index patients received zanamivir (10 a Families in which у1 member had influenza A(H3N2) viruses that were used for the sequence analysis in the present study. Identification nos. were given only to families in which influenza viruses of the same type/subtype were recovered from at least 2 members (index patients and contacts).
b Viruses were recovered from residents of Virginia, Michigan, South Carolina, Pennsylvania, Utah, Indiana, the United Kingdom, and Canada.
c Zanamivir was given to study participants who were 15 years of age (see Subjects, Materials, and Methods).
d The nucleotide sequences of the HA1 domain of the hemagglutinin gene of the viruses have been deposited in the GenBank database.
e Virus of the same type was isolated on study days 1 and 5. f Virus was recovered from a patient with influenza illness symptoms during the enrollment process, in January of 1999. mg) or placebo twice a day for 5 days. The other, healthy family members (contacts) received the same study drug (once daily for 10 days) that was given to the index patient.
Virus isolates. Respiratory secretions were collected on days 1 and 5 from index patients and within 1-3 days of onset of illness from contacts. Three groups of influenza A and B viruses were analyzed in the present study, including (1) viruses recovered from the index patients on days 1 and 5; (2) viruses recovered from the index patient (day 1) and from ill contacts within the same family; and (3) viruses recovered from members of families in which a single member was confirmed to be infected with influenza virus that also were residing in Albemarle County, Virginia (tables 1 and 2).
Virus isolation was performed exclusively in MDCK cells at 34ЊC, as described elsewhere [15] . When cytopathic effect was observed, cellular monolayers were tested by hemadsorption assay for the presence of virus replication, using 0.5% guinea pig red blood cells at 4ЊC. Testing for the presence of virus and determination of virus serotype also were performed by immunofluorescent staining. Aliquots of the virus were stored at Ϫ70ЊC for later analysis.
In our previous report [15] , we performed sequence analysis of the surface glycoproteins HA and neuraminidase of viruses recovered from the zanamivir-treated members of families in which influenza A or B virus infection was present. We did not observe any amino acid substitutions among the viruses recovered from members of the same family, which would be indicative of emergence or transmission of zanamivir-resistant viruses [16] . These results allowed us to conduct further analysis of the sequence heterogeneity of the HA of influenza viruses transmitted in households and circulating in the community, without regard to the treatment status of the household.
Serologic analysis. Serum samples collected from both index patients and contacts were obtained during the acute phase of the illness (on day 1) and during the convalescence (on day 28) and were analyzed for the presence of hemagglutination inhibition (HAI) antibodies to influenza A/Sydney/5/97(H3N2) virus at the National Institute for Biological Standards and Control, Hertfordshire, United Kingdom. "Seroconversion" was defined as a 4-fold increase in the HAI titers. The lowest detectable HAI titer was 1:10.
Sequence analysis of the HA gene. Viral RNA was extracted from infected cell culture supernatants with the RNeasy kit (Qiagen), according to the manufacturer's protocol. cDNA was synthesized with use of avian myeloblastosis virus reverse transcriptase (Promega) and U12 primer (5 -AGCAAAAGCAGG-3 ). Polymerase chain reaction (PCR) amplification was performed with the use of HotStart Taq polymerase (Qiagen), as described elsewhere [6] . After purification with the QIAquick PCR purification kit (Qiagen), sequencing reactions were performed at the Center of Biotechnology at the University of Virginia, Charlottesville, on template DNA with a Prism BigDye terminator (Applied Biosystems). Primer sequences are available on request. The sequence analysis of the HA1 domain of the HA genes of influenza A and B viruses was performed on codons 1-329 and codons 1-326, respectively; a signal peptide is omitted. Lasergene software (DNASTAR) was used to make the sequence alignments, and the dendrograms were constructed by the cluster method.
Nucleotide sequence accession numbers. The 38 sequences generated in the present study have been deposited in GenBank (acces- sion nos. AF501515-AF501535, AF297094, AF297096, AY096184-AY096192, AY112990-AY112992, and AY129960-AY129962; tables 1 and 2). The sequence for the A/Sydney/5/97(H3N2) reference strain was obtained from GenBank.
Results
In the present study, we analyzed the sequence heterogeneity of the HA gene that encodes the major antigen, HA, of influenza A and B viruses recovered during the winter through spring season of 1999. Considerable genetic heterogeneity of the HA gene sequences may be expected during a given epidemic season, especially when viruses are collected in different geographical areas.
Comparison of the HA1 sequences of the viruses recovered on days 1 and 5 of illness. First, we addressed the question of the HA1 nucleotide sequence variation of viruses recovered from the same index patient during the course of illness. The total number of index patients from whom influenza viruses were recovered was 137. Of those patients, 5 persons shed influenza A viruses and 5 shed influenza B viruses on both day 1 and day 5 of illness. The HA1 sequences of isolates recovered from the same patient were identical (tables 1 and 2), including those from the children (7, 10, and 16 years old) who had preexisting antibodies (HAI titers ranged from 1:15 to 1:30) against the influenza A(H3N2) strain of the previous epidemic season.
Families with evidence of influenza virus transmission between members. Thirty-six isolates were recovered from ill contacts in families, including 5 families that received zanamivir. Influenza viruses of the same antigenic type/subtype were recovered from both the index patient and the contact(s) within a 2-week period of observation in all families (tables 1 and 2). In 15 families, 2 virus isolates were available for analysis (1 from the index patient and 1 from a contact; tables 1 and 2), whereas in 5 families, 3 isolates were available for analysis (1 from the index case and 2 from contacts within the family). Thus, 45 virus isolates recovered from 20 index patients and 25 contacts were subjected to sequence analysis of the HA1 domain of the HA gene. Influenza A(H3N2) viruses were recovered from members of 14 families (table 1) , and influenza B viruses were recovered from members of 6 families (table 2). Families in which members were infected with influenza A viruses constituted a majority of all families from whom isolates were obtained for analysis (70%), which is in keeping with the percentage of influenza A attacks in the entire study (64%) [15] . In 85% of the families, school-age children (5-16 years old) were apparently the introducers of influenza viruses into the families. The proportions of children (44%) and adults (56%) were similar among contacts.
An important factor in establishing the likelihood of intrahousehold transmission is the time interval between virus recovery from the index patient and recovery from the contacts. In our study, the time period varied between 1 and 6 days (median, 4 days; , days) for the families mean ‫ע‬ SD 3.9 ‫ע‬ 1.7 with influenza A virus infections. In 3 instances (families F7, F8, and F19), the time interval was only 1 day, which raises the possibility that both the index patient and the ill contact in these families were infected simultaneously, from outside of the household. In the families with influenza B virus infections, the time intervals were 4-14 days (median, 7 days), which is longer than the intervals in the families with influenza A virus infections. Whether the presence of subclinical infections in other family members might have influenced these intervals is uncertain.
Nucleotide sequence analysis of the HA gene of influenza A(H3N2) viruses recovered from family members. First, we analyzed the HA1 nucleotide sequence of influenza A viruses recovered from members of the same family. In all 14 instances, the sequences of the viruses recovered within each family were identical (table 1) . In contrast, comparison of the interfamily sequences showed substantial variation among the families (figure 1) . Namely, the HA1 nucleotide sequences of the viruses from all but 2 families (F1 and F13) differed by at least 1 nucleotide. Nevertheless, when the analysis of the isolates recovered from the members of those 2 families was extended to the HA2 domain of the HA gene, a single nucleotide difference was detected (at residue 1053) between the isolates of F1 and F13. Thus, the nucleotide sequences of the HA gene of the viruses of each family were distinct, in comparison with those of viruses recovered from other families.
Analysis of HA1 nucleotide sequences of influenza A(H3N2) viruses circulating in the community.
Six families (F5-F10) in our study resided in Albemarle County (figure 1). Therefore, we wanted to examine the incidence of secondary transmissions within these families by examining the possibility of community-acquired infections. To probe the HA1 nucleotide sequence heterogeneity of the viruses circulating within this community, we performed additional analysis of 12 viruses collected from the families where only a single introduction of influenza virus was detected (table 1) . The combined analysis of the 18 HA1 nucleotide sequences of the viruses collected in a single community in Virginia revealed that 15 (83%) of them differed by at least 1 residue (figure 1). The most distant HA1 variants (namely, isolates 21794 and 21847) differed by 21 nucleotide residues.
Overall, we analyzed the HA1 nucleotide sequences of 47 viruses recovered from 30 families with influenza A(H3N2) viruses that resided in geographically distant sites, including the United States, Canada, and the United Kingdom (in 14 families, viruses were recovered from both an index patient and from contact cases, and in 16 families, viruses were recovered either from the index patient or from a contact case) (table 1 and figure 1). We identified 23 sequence variants among these 30 isolates, 14 of which were recovered from residents of Albemarle County (figure 1). Therefore, it appeared to be substantially more likely that family members would acquire a HA1 nucleotide variant identical to that of the index patient from a member of the household than that such a variant would be acquired from outside contacts in the community. However, in considering these results, it is important to remember that, although sequencing can effectively rule out chains of transmission by identifying distinct strains of virus, it cannot conclusively prove that chains of transmission exist. One isolate from Virginia (VA/21833) had an HA1 nucleotide sequence that was identical to 2 other isolates recovered from residents of South Carolina and the United Kingdom; in addition, 2 isolates, 1 from Pennsylvania and 1 from Michigan, also shared the identical HA1 nucleotide sequence (figure 1).
Amino acid sequence heterogeneity of the HA1 of influenza A(H3N2) virus isolates.
Compared with A/Sydney/5/97, which was included in a trivalent vaccine formulation for the influenza season of 1998-1999, the viruses collected in our study during the winter through spring season of 1999 contained 7-11 amino acid substitutions in the HA1 molecule (table 3) . Four substitutions, at positions 3, 142, 194, and 226, were identical in all isolates and different from the sequence of the reference strain, A/Sydney/5/97. Three of these changes occurred at codons 142, 194, and 226, which reside in the antibody-binding sites A and B and in the receptor-binding site, respectively, and are known to be positively selected during antigenic drift [16, 17] . Two isolates had substitutions at position 186, which is in the antigenic site B and is also implicated in positive selection. Overall, we identified 16 amino acid sequence variants, of which 11 were detected in viruses from Albemarle County (table 3) . This is not surprising, because there is a large body of students at the University of Virginia who travel during winter break. The most common amino acid variant (VA/21799; table 3) was isolated from at least 1 member of 10 families residing in geographically distant areas (Virginia, South Carolina, the United Kingdom, and Canada). 
Sequence analysis of the HA1 of influenza B viruses.
The HA1 nucleotide sequences of the viruses recovered from the index cases in the families F2, F12, F14, F16, and F21 differed from each other and from the sequences of the viruses recovered from the index cases of the families in which no second event was detected (figure 2). The members of families F2, F12, and F16 shed influenza B viruses with HA1 nucleotide sequences that were identical within each family (table 2 and figure 2), as was true for families with influenza A viruses. In family F15, the sequences of the index patient and 1 of 2 contacts were identical, whereas the second contact had a 1-nt difference. Similarly, a 1-nt difference was detected between the sequences of viruses recovered from members of family F21 (figure 2). A 4-nt difference between sequences was detected in family F14; in this family, the viruses were recovered from teenaged twins who had illness separated by a 2-week interval. To confirm that the observed differences were not artifacts introduced during reverse-transcriptase PCR amplification of the HA genes, the sequence analysis of the isolates was repeated; this yielded the same results. Overall, we identified 13 nucleotide sequence variants in influenza B viruses (table 2), which encoded 8 amino acid sequence variants (table 4) . On the basis of the amino acid residues detected at positions 29, 75, and 219, the virus isolates could be placed in 2 distinct groups (table 4). No differences were detected in the HA1 amino acid sequences of influenza B viruses recovered from members of the same family, with 1 exception: isolates MI/22687 and MI/22691 (both from family F14) differed by a single amino acid residue at position 118 (ArgrLys). The members of this family had been assigned to receive placebo, and, therefore, this substitution was not drug related (table 2) .
Discussion
This study used sequence analysis of the hemagglutinin gene (HA1 domain) to examine the molecular epidemiology of influenza virus transmission within households during a single influenza season. We found that the amino acid sequences of the HA1 molecules of influenza A and B viruses recovered within each family were identical in 19 of 20 families examined. Notably, the observed identity was extended to the HA1 nucleotide sequence of all influenza A viruses recovered from the members of the same family. Additionally, HA1 nucleotide sequences of influenza A and B viruses recovered at both day 1 and day 5 of illness from the same patient were identical in 10 pairs examined, which indicated that the viruses had not been subjected to selection. Other evidence for conservation of the viral genome was the recovery of 3 isolates from residents of Virginia, South Carolina, and the United Kingdom that had the identical HA1 nucleotide sequence. The human infectious dose of influenza A virus is estimated, based on experimental small-particle (1-5 mm) aerosol exposure, to be 1-5 TCID 50 [18] . For RNA viruses, the consensus nucleotide sequence of population equilibrium can remain unchanged if a large number of virus particles replicate during each of successive infections and if representative progeny populations are always transmitted [1] . Therefore, to explain the substantial conservation of the consensus sequence of the viral genome during influenza virus transmission in the families and its occasional conservation during multiple transmissions, we hypothesize that a relatively large number of infectious particles are being transmitted from infected to susceptible hosts on a regular basis.
If viruses with virtually identical nucleotide sequences cir- /22572  ------I  --MI/22631 and  UT/20975  A  I  -----I  -UK/34304 and  MI/22691  A  I  ---K  -I  -MI/22687  A  I  K  --K  -I  -KS/24992  A  I  --G  K  -I  - NOTE. -, no difference from consensus sequence. a Sequence shared by the isolates MI/22721 and SC/25723.
culate within a community (e.g., VA/21725, VA/21730, and VA/ 21720; figure 1), it is possible that, at least in some families (e.g., family F6), virus has been acquired from a community contact rather than from a contact within the family. However, the short time interval between the development of symptoms in the index patient and in contacts in majority of the families suggests that secondary transmission has occurred within these households. To increase the power of the analysis of transmission links, extension of the sequence analysis to the whole HA gene, and probably to the other viral genes, would be beneficial. Thus, the inclusion of the HA2 domain of the HA gene in the sequence analysis allowed differentiation of the isolates recovered from the families from Pennsylvania (family F1) and Michigan (family F13). The molecular mechanisms that drive the antigenic drift of the HA of influenza A viruses are not well understood. The existence of selective forces that may favor amino acid substitutions in antigenically relevant sites but are unrelated to immune response (e.g., substitutions that improve virus-cell receptor interaction) should be considered [1, 8] . It is widely accepted that changes in the antibody-binding sites (A-E) of HA1 lead to the inability of preexisting antibodies to neutralize the novel virus variant. Nakajima et al. [4] found that the antigenic regions of the HA molecule that are responsible for production of anti-HA antibodies vary from person to person (especially among young children) and proposed a model for emergence of drift variants by sequential changes during reinfection of individuals. To this end, sequence analysis of the HA gene was recently used in the Houston Family Study [19] to investigate the molecular basis of reinfection and show that reinfection of young children by influenza A(H3N2) viruses may occur within a short period of time (1-3 years) and could be caused by viruses carrying a limited number of substitutions in the HA1 [19] . Interestingly, reinfection did not necessarily require acquisition of substitutions at the positively selected codons in HA1 [17, 20] .
In our study, the majority of the index patients were schoolage children (85%). The identity of the HA sequences of the viruses within the families reinforced the hypothesis that schoolage children play a significant role in the introduction of the virus into households. Previous studies found that antigenic HA variants of influenza A(H3N2) viruses may be selected in vitro by serum samples from very young children [4, 5] . However, it is difficult to detect and even more difficult to prove the emergence of antibody-escape mutants after influenza illness in a young child by analyzing the HA1 sequences of recovered viruses. In our study, the number of children who had preexisting antibodies against A/Sydney/5/97 was rather low (n p ). Therefore, as would be expected, we did not detect escape-10 mutant emergence by comparing the HA1 sequences of viruses recovered within families or by comparing the sequences of day 1 and day 5 isolates.
In 2 families (F15 and F21) with influenza B virus infections, we observed a minimal difference (a single residue) between the HA1 nucleotide sequences of the viruses recovered from members of the same family. We attribute this to a random sampling event resulting from transmission of a small number of infectious particles (or even a single infectious particle) that altered the consensus of the HA sequence of the quasi species without alteration of the HA1 protein sequence. In family F14, the 4-nt difference between the sequences of the isolates and the longer interval (2 weeks) between recovery of viruses from the members of this family points to independent introduction of viruses into the family. The possibility that sequential transmission had occurred within the family, leading to a second, asymptomatic infection, also could not be excluded. Although the difference between the HA1 nucleotide sequences of intrafamily isolates was observed only in families with influenza B viruses, the small number of those families does not allow a conclusion to be drawn about the possible difference between transmission of influenza A and B viruses within households.
A better understanding of variation in viral proteins as a result of different selective pressures in an individual and on a population level is of substantial practical use, given the current accelerated development of new vaccines and antiviral agents, including neuraminidase inhibitors and inhibitors of viral binding and fusion. The household is an important environment in the assessment of prophylaxis and treatment efficacies and possible transmissibility of drug-resistant viruses [10, 11, 15] . For example, a high frequency of resistance emergence and transmission were observed with use of the M2 inhibitor rimantadine [10] , but not with use of the neuraminidase inhibitor zanamivir [15] or oseltamivir [21] , for treatment of index patients and for postexposure prophylaxis in healthy household contacts. Public health concerns make necessary a detailed analysis of changes in the viral genome that may be induced by therapeutic interventions and their effect on virus evolution. If changes in HA are anticipated, for example, as a result of the use of antiviral drugs [9, 22] , the existence of these sources of HA variability should be considered in the analysis of detected mutations.
